Overcoming Anti-PD-1 Resistance in Melanoma by Targeting Immunologic Mediators of the Gli2 Pathway
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
The Melanoma Research Foundation
Start Date
September 30, 2022
End Date
September 29, 2025
Administered By
Medicine, Medical Oncology
Awarded By
The Melanoma Research Foundation
Start Date
September 30, 2022
End Date
September 29, 2025